A 1994 working group report from the CDC defines the public health impact of drug-resistant Streptococcus pneumoniae (DRSP). The report describes three goals addressing surveillance, epidemiologic investigation, and prevention and control of DRSP. It was developed by a group of public health practitioners, clinical laboratorians, healthcare providers, and professional society representatives.
Use Cases
- Analyzing the public health burden of S. pneumoniae based on estimated annual case counts for meningitis, bacteremia, pneumonia, and otitis media mentioned in the description
- Studying the emergence and spread of penicillin-resistant and multidrug-resistant S. pneumoniae strains in the United States
- Developing surveillance strategies for non-reportable conditions like DRSP infection based on the working group's objectives
- Informing empirical antimicrobial therapy choices for presumptive S. pneumoniae infections based on the described diagnostic challenges
Strengths
- Provides specific annual U.S. morbidity estimates: 3,000 meningitis cases, 50,000 bacteremia cases, 500,000 pneumonia cases, and 7,000,000 otitis media cases
- Describes a concrete public health action: a CDC-convened working group in June 1994
- Outlines a structured strategy with three defined goals for addressing DRSP
Limitations
- Row count is unknown, which may limit suitability assessment
- Column-level documentation is absent; field semantics must be inferred after download
- Last update date is unknown; freshness unverified
Provenance
- Source
- Centers for Disease Control and Prevention (CDC) working group
- Collection Method
- Working group report
- Time Range
- 1994
- Geography
- United States